A 1000 mg ×2 induction regimen followed by maintenance every 6–12 months was associated with near-elimination of relapse ...
Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...
We asked AI models to do a simple task,” researchers said. “Instead, they defied their instructions … to preserve their peers ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline ...
The day when a quantum computer manages to break common encryption, or Q-Day, is fast approaching, and the world is not close ...
If it sometimes feels like your phone is listening to you and reading your mind, tech expert Aakash Gupta says you're not ...
There are significant disagreements about whether the industry's economic benefits are worth the combined $457 million in projected tax abatements that Nevada has doled out over the past decade.
Prescriptions for an adalimumab biosimilar among new users rose from 0% to 24% after CVS Caremark added it to its formulary, ...
Researchers observed AI models sabotaging shutdown mechanisms and inflating evaluations to protect peer systems, highlighting ...
It's starting to feel like every service now requires a subscription, and the costs involved can quickly add up.